Inventor · disambiguated record
Gunnar Garke
Also filed as: GARKE GUNNAR
6 granted patents·1 pending application·23 citations·filing 2007–2020
78Inventor score
Top patents by PatentIndex Score
7 records- 0190US10399977B2Process for preparing (4S)- 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and purification thereof for use as a pharmaceutical active ingredientBayer Pharma AG·Filed 2018·Granted Sep 3, 2019·7 cites·24 claims
- 0282US10059707B2Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro- 1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredientBayer Pharma AG·Filed 2015·Granted Aug 28, 2018·3 cites·24 claims
- 0382US8053426B2Progesterone receptor antagonistsBAYER SCHERING PHARMA AG·Filed 2007·Granted Nov 8, 2011·12 cites·28 claims
- 0472USRE49860EProcess for preparing (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and purification thereof for use as pharmaceutical active ingredientBayer Pharma AG·Filed 2020·Granted Mar 5, 2024·0 cites·28 claims
- 0570US9592308B2Method for production of F-18 labeled amyloid beta ligandsPIRAMAL IMAGING SA·Filed 2016·Granted Mar 14, 2017·1 cites·14 claims
- 0661USRE49575EMethod for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-l,4-dihydro-1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredientBayer Pharma AG·Filed 2015·Granted Jul 11, 2023·0 cites·24 claims
- 0741US2013209363A1Method for production of f-18 labeled amyloid beta ligandsBERNDT MATHIAS·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gunnar Garke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →